Oscar Health (OSCR)
(Delayed Data from NYSE)
$17.56 USD
-0.33 (-1.84%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $17.55 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OSCR 17.56 -0.33(-1.84%)
Will OSCR be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for OSCR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OSCR
Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now?
Why Fast-paced Mover Oscar Health, Inc. (OSCR) Is a Great Choice for Value Investors
OSCR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Despite Fast-paced Momentum, Oscar Health, Inc. (OSCR) Is Still a Bargain Stock
Oscar Health, Inc. (OSCR) Is Attractively Priced Despite Fast-paced Momentum
Oscar Health, Inc. (OSCR) Shows Fast-paced Momentum But Is Still a Bargain Stock
Other News for OSCR
Longleaf Partners Small-Cap Fund Q1 2024 Commentary
Auxa Health secures $5.2 in Funding to Drive Benefit Navigation
Largest borrow rate increases among liquid names
First Week of OSCR June 21st Options Trading
2024 Appian Innovation Award Winners Demonstrate Significant Business Results with Next-Gen AI Process Automation